Squarex Pharmaceutical Corporation (SQRX)

Squarex Pharmaceutical Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Year	2021	2020
Cash & Equivalents	0.04	0
Cash & Cash Equivalents	0.04	0
Cash Growth	682.90%	-
Other Current Assets	0.04	0
Total Current Assets	0.07	0
Goodwill and Intangibles	0.01	-
Total Long-Term Assets	0.01	0
Total Assets	0.09	0
Accounts Payable	0.05	-
Current Debt	0.03	-
Other Current Liabilities	0.29	0.2
Total Current Liabilities	0.37	0.2
Long-Term Debt	0.54	0.31
Total Long-Term Liabilities	0.54	0.31
Total Liabilities	0.9	0.51
Total Debt	0.56	0.31
Debt Growth	82.97%	-
Retained Earnings	-7.7	-7.34
Shareholders' Equity	-0.82	-0.51
Net Cash / Debt	-0.53	-0.3
Working Capital	-0.3	-0.2

Source: IPO financials are sourced from S-1 and S-1/A filings submitted to the Securities and Exchange Commission (SEC).